Literature DB >> 10498623

Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant.

L Yu1, A R Cross, L Zhen, M C Dinauer.   

Abstract

Chronic granulomatous disease (CGD) is a group of inherited disorders in which phagocytes are unable to generate superoxide (O(2)(-)) due to genetic defects in any 1 of 4 essential NADPH oxidase components. Mutations in the X-linked gene for gp91(phox), the large subunit of the flavocytochrome b(558) heterodimer, account for the majority of CGD. An X-CGD patient in which a splice junction mutation results in an in-frame deletion of 30 nucleotides encoding amino acids 488 to 497 of gp91(phox) (delta488-497 gp91(phox)) has previously been reported. In this study, we generated myeloid PLB-985 cells expressing the mutant triangle delta488-497 gp91(phox) to further characterize its functional properties. These cells mimicked the phenotype of the patient's neutrophils with normal expression of a nonfunctional delta488-497 gp91(phox) flavocytochrome. Translocation of p47(phox) and p67(phox) to delta488-497 gp91(phox) PLB-985 plasma membranes was not affected, as determined both in activated intact cells and in the cell-free system. Furthermore, a synthetic peptide corresponding to residues 488-497 of gp91(phox) was relatively ineffective in inhibiting O(2)(-) production in the cell-free oxidase assay (IC50, approximately 500 micromol/L), suggesting that residues 488-497 of gp91(phox) are not directly involved in oxidase assembly. Mutant delta488-497 gp91(phox) flavocytochrome failed to support iodonitrotetrazolium (INT) reduction, showing a disruption of electron transfer from NADPH to the FAD center of gp91(phox). However, the FAD binding capacity of the mutant flavocytochrome was normal, as measured by equilibrium dialysis. Taken together, these results suggest that the delta488-497 deletion in gp91(phox) disrupts electron transfer to FAD, either due to a defect in NADPH binding or to impaired delivery of electrons from NADPH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498623

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

2.  Regulation of NADPH oxidase activity in phagocytes: relationship between FAD/NADPH binding and oxidase complex assembly.

Authors:  Franck Debeurme; Antoine Picciocchi; Marie-Claire Dagher; Didier Grunwald; Sylvain Beaumel; Franck Fieschi; Marie-José Stasia
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

3.  Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.

Authors:  Marie José Stasia; Pierre Bordigoni; Daniel Floret; Jean Paul Brion; Cécile Bost-Bru; Gérard Michel; Pierre Gatel; Denis Durant-Vital; Marie Antoinette Voelckel; Xing Jun Li; Michèle Guillot; Elisabeth Maquet; Cécile Martel; Françoise Morel
Journal:  Hum Genet       Date:  2004-11-06       Impact factor: 4.132

4.  p40(phox) Participates in the activation of NADPH oxidase by increasing the affinity of p47(phox) for flavocytochrome b(558).

Authors:  A R Cross
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

5.  Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.

Authors:  Clara Bionda; Xing Jun Li; Robin van Bruggen; Michel Eppink; Dirk Roos; Françoise Morel; Marie-José Stasia
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

6.  Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.

Authors:  Anne M Sanders; John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Arta M Monjazeb; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-03-31       Impact factor: 4.430

Review 7.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28

8.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

Review 9.  Towards specific NADPH oxidase inhibition by small synthetic peptides.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Axel Périanin
Journal:  Cell Mol Life Sci       Date:  2012-05-06       Impact factor: 9.261

Review 10.  NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS.

Authors:  Eugenia Cifuentes-Pagano; Gabor Csanyi; Patrick J Pagano
Journal:  Cell Mol Life Sci       Date:  2012-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.